Forrest Health’s Post

Reoperation rates after breast-conserving surgery (BCS) have remained high and contributed to increased healthcare costs and patient complications, according to a recent MD Anderson Cancer Center and The University of Texas Health Science Center at Houston (UTHealth Houston) study. Join our webinar to hear #breastcancer surgeons, Drs. Nina Tamirisa and Ted James, highlight: • Current statistics and trends in reoperation rates following BCS • Implications for patients and healthcare systems • Strategies to reduce reoperations Register now at https://lnkd.in/egNxpYef. #webinar #breastcancerawareness #patientcare

The October issue is available online! https://lnkd.in/g334bF8z On the Cover: Big Changes and Big Gains in US DCD Organ Procurement. Donors after circulatory determination of death (DCD) have historically yielded fewer organs per donor. However, normothermic regional perfusion (NRP), a procurement strategy that entails rapid re-establishment of organ perfusion after determination of death, mitigates the ischemic organ injury incurred after withdrawal of life-sustaining treatment. A center at the forefront of DCD-NRP in the US, the University of Colorado Hospital Transplant Center (Bakhtiyar et al.) analyzed OPTN data and found DCD-NRP organ yields exceeded standard DCD procurement and matched donation after brain death procurement. Using single center data, they report on cost and resource utilization, key considerations along with the need for regulatory guidance and professional infrastructure that our editorialists, Hobeika and Roll, will challenge the rapid expansion of DCD-NRP. Cover design by Megan Llewellyn, CMI, Department of Surgery, Duke University.

update of the BIA-AlCL management consensus, important paper for all those professionals who manage breast pathology #breastsurgery #biaalcl #lymphoma #breastimplants #oncology

In a recent MD Anderson Cancer Center study analyzing re-excision rates in breast-conserving surgery and associated healthcare costs, "Reoperations were associated with 24% higher costs in both the commercial and Medicare cohorts, which translated into $21,607 and $8559 incremental costs, respectively." Read the study and learn how reoperations in #breastcancer care contribute to increased financial burden on the healthcare system. https://lnkd.in/e4Cj88GT

Congratulations to Dr. Youssef Soliman on his recent publication in the World Journal of #gastrointestinal #endoscopy along side Shravani Reddy, James Lin and Megan Soliman MD MSc. It was a privilege for me to collaborate with him and our esteemed colleagues on this article. Here are some key highlights:                •            #Organpreservation has been a century-long endeavor, requiring #multidisciplinary #collaboration between #medicaloncologists, #surgeons, #radiationoncologists, and #endoscopists, whether they are #gastroenterologists or #endoscopicsurgeons.                •            The role of #endoscopicablation is poised to become increasingly significant due to ongoing technological advancements.                •            Conditions likely to benefit from these innovations include #esophagealcancer, #rectalcancer, and #pancreaticobiliary #cancers, especially considering the significant #qualityoflife improvements compared to traditional surgery. We’re excited to see how these developments will shape the future of patient care. #MedicalInnovation #Healthcare #Endoscopy #SurgicalAdvancements #Oncology #QualityOfLife #Gastroenterology

Don’t miss the opportunity to meet our CEO, Juliane Bernholz, PhD, at the 8th edition of the Kidney Disease Clinical Trialists Workshop in Washington, DC, from March 15-16. As a speaker, she will give an industry view of clinical trials in kidney disease and discuss the current Phase 2 study of ilofotase alfa for the preventative treatment of cardiac surgery-associated renal damage.   #KDCT #kidneydisease

📣 Meet Mrs Julie Cornish, Consultant Colorectal Surgeon at the University Hospital of Wales in Cardiff. Julie specialises in pelvic floor health and is leading pioneering research into low anterior resection syndrome (LARS), a condition that affects some people after surgery to remove part of the bowel. 🔬 Julie’s research focuses on tackling the debilitating symptoms of LARS, such as faecal incontinence and urgency. Her POLARiS study, funded initially by Bowel Research UK, investigated treatment options for LARS and secured £1.8M from the National Institute for Health Research to expand the trial across the UK and internationally. 🧪 Through her research, Julie hopes to improve quality of life for bowel cancer patients, providing better treatment options and ensuring support is more accessible. 💡 Read more about Julie, her career, and her life-changing research: https://lnkd.in/eeEcQ45m 🌐 Want to be featured in our researcher profiles? Like, share, and comment on our posts to help spread the word about our amazing researchers. Email press@bowelresearchuk.org to get involved! #LARS #BowelResearch #MedicalResearch #CancerResearch #BowelDisease #Research #BowelPatient #BowelCancer #LowAnteriorResectionSyndrome

Life following an amputation is turbulent and filled with a lot of unknowns. But if due to infection, cancer, or trauma, amputation becomes a life preserving procedure, we can help your patients regain independence and mobility. When the unthinkable happens, we are here to help ease that transition from immobility to mobility by managing integrated prosthetics care right in your medical practice. Our scientifically validated care model assures the best outcome and new revenue stream for your practice. Explore more: https://lnkd.in/eB7Rbet Society for Vascular SurgeryVascular SpecialistAmputee Coalition

** Calling all UK Consultants in Surgery, Anaesthetist, Critical care, Older People Medicine and Healthcare Professionals in Elective Cancer Pathways ** Link: https://lnkd.in/eykz6fsN What is it about? To understand how well current elective cancer pathways are set up for people with multiple long-term conditions or multimorbidity. Why is it important? > Increasingly, we are seeing patients undergoing elective surgery with multimorbidity, with 7 million people undergoing surgery > New data @Anaes_Journal shows these patients have lower 30-day mortality but also lower quality of life > Growing national interest to ensure healthcare systems are better prepared for the growing population with multimorbidity. What is the output? Findings of the study will be published under a corporate authorship model, importantly understand opportunities to strengthen current pathways. We have response from 39 NHS trust covered so far! NHS England

🚨Benefits Leaders: Are you overpaying for worse healthcare results?   If you're managing benefits at a large company, you know that higher healthcare costs don’t always translate to better results. But how do you ensure your employees are getting high-quality specialty care—without breaking the bank? 🤔   Join us for a webinar tomorrow where we’ll dive deep into the complexities of specialty care: MSK, bariatric surgery, cancer care, and infusion therapy.   What You'll Learn:   📊 Key quality metrics that matter most for driving impactful healthcare benefits 💡 Strategies to enhance quality while reducing healthcare costs 🎤 Real-world insights: Hear how an industry leader evaluated quality and selected their surgical COE   📅 Register today: https://lnkd.in/gEQSUbet